Literature DB >> 29891729

NOS3 Inhibition Confers Post-Ischemic Protection to Young and Aging White Matter Integrity by Conserving Mitochondrial Dynamics and Miro-2 Levels.

Chinthasagar Bastian1, Jane Zaleski1, Katharine Stahon1, Brandon Parr1, Andrew McCray1, Jerica Day1, Sylvain Brunet1, Selva Baltan2.   

Abstract

White matter (WM) damage following a stroke underlies a majority of the neurological disability that is subsequently observed. Although ischemic injury mechanisms are age-dependent, conserving axonal mitochondria provides consistent post-ischemic protection to young and aging WM. Nitric oxide synthase (NOS) activation is a major cause of oxidative and mitochondrial injury in gray matter during ischemia; therefore, we used a pure WM tract, isolated male mouse optic nerve, to investigate whether NOS inhibition provides post-ischemic functional recovery by preserving mitochondria. We show that pan-NOS inhibition applied before oxygen-glucose deprivation (OGD) promotes functional recovery of young and aging axons and preserves WM cellular architecture. This protection correlates with reduced nitric oxide (NO) generation, restored glutathione production, preserved axonal mitochondria and oligodendrocytes, and preserved ATP levels. Pan-NOS inhibition provided post-ischemic protection to only young axons, whereas selective inhibition of NOS3 conferred post-ischemic protection to both young and aging axons. Concurrently, genetic deletion of NOS3 conferred long-lasting protection to young axons against ischemia. OGD upregulated NOS3 levels in astrocytes, and we show for the first time that inhibition of NOS3 generation in glial cells prevents axonal mitochondrial fission and restores mitochondrial motility to confer protection to axons by preserving Miro-2 levels. Interestingly, NOS1 inhibition exerted post-ischemic protection selectively to aging axons, which feature age-dependent mechanisms of oxidative injury in WM. Our study provides the first evidence that inhibition of glial NOS activity confers long-lasting benefits to WM function and structure and suggests caution in defining the role of NO in cerebral ischemia at vascular and cellular levels.SIGNIFICANCE STATEMENT White matter (WM) injury during stroke is manifested as the subsequent neurological disability in surviving patients. Aging primarily impacts CNS WM and mechanisms of ischemic WM injury change with age. Nitric oxide is involved in various mitochondrial functions and we propose that inhibition of glia-specific nitric oxide synthase (NOS) isoforms promotes axon function recovery by preserving mitochondrial structure, function, integrity, and motility. Using electrophysiology and three-dimensional electron microscopy, we show that NOS3 inhibition provides a common target to improve young and aging axon function, whereas NOS1 inhibition selectively protects aging axons when applied after injury. This study provides the first evidence that inhibition of glial cell NOS activity confers long-lasting benefits to WM structure and function.
Copyright © 2018 the authors 0270-6474/18/386247-20$15.00/0.

Entities:  

Keywords:  Miro-2; ischemia; mitochondria; nitric oxide synthase; oxidative stress; white matter

Mesh:

Substances:

Year:  2018        PMID: 29891729      PMCID: PMC6041791          DOI: 10.1523/JNEUROSCI.3017-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  104 in total

1.  The effects of nitric oxide on electron transport complexes.

Authors:  R Welter; L Yu; C A Yu
Journal:  Arch Biochem Biophys       Date:  1996-07-01       Impact factor: 4.013

Review 2.  The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future.

Authors:  E Clementi; J Meldolesi
Journal:  Trends Pharmacol Sci       Date:  1997-08       Impact factor: 14.819

3.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.

Authors:  J C Drapier; J B Hibbs
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

4.  Neurovascular protection by ischaemic tolerance: role of nitric oxide.

Authors:  Costantino Iadecola; Timo Kahles; Eduardo F Gallo; Josef Anrather
Journal:  J Physiol       Date:  2011-07-11       Impact factor: 5.182

5.  Endothelial nitric oxide synthetase (eNOS) in astrocytes: another source of nitric oxide in neocortex.

Authors:  A E Wiencken; V A Casagrande
Journal:  Glia       Date:  1999-06       Impact factor: 7.452

6.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.

Authors:  S Dimmeler; I Fleming; B Fisslthaler; C Hermann; R Busse; A M Zeiher
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

7.  Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.

Authors:  F Zhang; R M Casey; M E Ross; C Iadecola
Journal:  Stroke       Date:  1996-02       Impact factor: 7.914

Review 8.  From nitric oxide to endothelial cytosolic Ca2+: a negative feedback control.

Authors:  Xiaoqiang Yao; Yu Huang
Journal:  Trends Pharmacol Sci       Date:  2003-06       Impact factor: 14.819

9.  Microglia provide neuroprotection after ischemia.

Authors:  Jens Neumann; Matthias Gunzer; Herwig O Gutzeit; Oliver Ullrich; Klaus G Reymann; Klaus Dinkel
Journal:  FASEB J       Date:  2006-02-10       Impact factor: 5.191

10.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.

Authors:  H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

View more
  8 in total

1.  Preserving Mitochondrial Structure and Motility Promotes Recovery of White Matter After Ischemia.

Authors:  Chinthasagar Bastian; Jerica Day; Stephen Politano; John Quinn; Sylvain Brunet; Selva Baltan
Journal:  Neuromolecular Med       Date:  2019-05-31       Impact factor: 3.843

2.  Oxygen-Glucose Deprivation Decreases the Motility and Length of Axonal Mitochondria in Cultured Dorsal Root Ganglion Cells of Rats.

Authors:  Shin Kikuchi; Takayuki Kohno; Takashi Kojima; Haruyuki Tatsumi; Yuki Ohsaki; Takafumi Ninomiya
Journal:  Cell Mol Neurobiol       Date:  2022-06-30       Impact factor: 4.231

3.  IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.

Authors:  Ruchi Roy; Janet Zayas; Mohamed F Mohamed; Anahita Aboonabi; Kaylee Delgado; Jennillee Wallace; Mohammad Bayat; Timothy M Kuzel; Jochen Reiser; Sasha H Shafikhani
Journal:  J Invest Dermatol       Date:  2021-09-10       Impact factor: 7.590

Review 4.  CK2 inhibition protects white matter from ischemic injury.

Authors:  Selva Baltan; Chinthasagar Bastian; John Quinn; Danielle Aquila; Andrew McCray; Sylvain Brunet
Journal:  Neurosci Lett       Date:  2018-08-17       Impact factor: 3.197

5.  CK2 inhibition confers functional protection to young and aging axons against ischemia by differentially regulating the CDK5 and AKT signaling pathways.

Authors:  Chinthasagar Bastian; John Quinn; Ajai Tripathi; Danielle Aquila; Andrew McCray; Ranjan Dutta; Selva Baltan; Sylvain Brunet
Journal:  Neurobiol Dis       Date:  2018-06-23       Impact factor: 7.046

6.  Identification of miRNAs That Mediate Protective Functions of Anti-Cancer Drugs During White Matter Ischemic Injury.

Authors:  Selva Baltan; Ursula S Sandau; Sylvain Brunet; Chinthasagar Bastian; Ajai Tripathi; Hung Nguyen; Helen Liu; Julie A Saugstad; Yalda Zarnegarnia; Ranjan Dutta
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 5.200

Review 7.  Casein Kinase 2 Signaling in White Matter Stroke.

Authors:  Hung Nguyen; Wenbin Zhu; Selva Baltan
Journal:  Front Mol Biosci       Date:  2022-07-13

8.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.

Authors:  Nicola J Armstrong; Karen A Mather; Muralidharan Sargurupremraj; Maria J Knol; Rainer Malik; Claudia L Satizabal; Lisa R Yanek; Wei Wen; Vilmundur G Gudnason; Nicole D Dueker; Lloyd T Elliott; Edith Hofer; Joshua Bis; Neda Jahanshad; Shuo Li; Mark A Logue; Michelle Luciano; Markus Scholz; Albert V Smith; Stella Trompet; Dina Vojinovic; Rui Xia; Fidel Alfaro-Almagro; David Ames; Najaf Amin; Philippe Amouyel; Alexa S Beiser; Henry Brodaty; Ian J Deary; Christine Fennema-Notestine; Piyush G Gampawar; Rebecca Gottesman; Ludovica Griffanti; Clifford R Jack; Mark Jenkinson; Jiyang Jiang; Brian G Kral; John B Kwok; Leonie Lampe; David C M Liewald; Pauline Maillard; Jonathan Marchini; Mark E Bastin; Bernard Mazoyer; Lukas Pirpamer; José Rafael Romero; Gennady V Roshchupkin; Peter R Schofield; Matthias L Schroeter; David J Stott; Anbupalam Thalamuthu; Julian Trollor; Christophe Tzourio; Jeroen van der Grond; Meike W Vernooij; Veronica A Witte; Margaret J Wright; Qiong Yang; Zoe Morris; Siggi Siggurdsson; Bruce Psaty; Arno Villringer; Helena Schmidt; Asta K Haberg; Cornelia M van Duijn; J Wouter Jukema; Martin Dichgans; Ralph L Sacco; Clinton B Wright; William S Kremen; Lewis C Becker; Paul M Thompson; Thomas H Mosley; Joanna M Wardlaw; M Arfan Ikram; Hieab H H Adams; Sudha Seshadri; Perminder S Sachdev; Stephen M Smith; Lenore Launer; William Longstreth; Charles DeCarli; Reinhold Schmidt; Myriam Fornage; Stephanie Debette; Paul A Nyquist
Journal:  Stroke       Date:  2020-06-10       Impact factor: 7.914

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.